The core needle and surgical biopsy concordance to detect estrogen, progesterone, and her-2 receptors in breast cancer: A comparative study

8Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Background &Objectives: Evaluation of estrogen receptor (ER), progesterone receptor (PR), and (human epidermal growth factor receptor-2) Her-2 on core needle biopsies (CNBs) is increasingly in use to diagnosis early breast cancer, but its concordance with surgical excision (SE) is not well documented. Methods: The study included 100 formalin fixed, paraffin-embedded specimens of invasive breast carcinoma archived in Pathology Department of Cancer Institute, Tehran, Iran, from 2011 to 2014. Immunohistochemistry was applied to detect ER, PR, and Her-2. Results: The current study findings indicated a significant correlation of 90% between CNB and SE specimens for ER expression. The correlation between CNB and SE specimens was estimated as 81% and 97.3% for PR and Her-2, respectively. Discussion: CNB can be performed confidently to determine ER and Her-2. For PR, results obtained from CNB should be considered.

Cite

CITATION STYLE

APA

Ensani, F., Omranipour, R., Jahanzad, I., Jafari, A., Nafarzadeh, S., & Aminishakib, P. (2017). The core needle and surgical biopsy concordance to detect estrogen, progesterone, and her-2 receptors in breast cancer: A comparative study. Iranian Journal of Pathology, 12(3), 202–208. https://doi.org/10.30699/ijp.2017.25042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free